Novartis Pharma Schweizerhalle AG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Switzerland
- Registered address
- Rothausstrasse, Pratteln CH, 4133, Switzerland (CHE)
- Operations here
- analysisapi manufacturemanufactureparticle size reduction
- FDA identifiers
- FEI 3002865753 · DUNS 481963890
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-03-27
- NAIDrug Quality Assurance2022-08-25
- VAIDrug Quality Assurance2017-06-23
- NAIDrug Quality Assurance2015-07-14
- NAIDrug Quality Assurance2012-09-25
- VAIDrug Quality Assurance2010-07-09
- NAIDrug Quality Assurance2009-09-10
Drugs this plant is listed as making
0 distinct drugs across 0 products name this site in their FDA label.
No drug labels currently list this site.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.